These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9127469)

  • 1. Biochemical markers in menopausal women.
    Griesmacher A; Peichl P; Pointinger P; Mateau R; Bröll H; Hartl W; Gruber W
    Scand J Clin Lab Invest Suppl; 1997; 227():64-72. PubMed ID: 9127469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between female sex hormones and biochemical markers of bone turnover in peri- and postmenopausal women.
    Peichl P; Griesmacher A; Pointinger P; Marteau R; Hartl W; Gruber W; Bröll H
    Calcif Tissue Int; 1998 May; 62(5):388-94. PubMed ID: 9541515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.
    Papakitsou EF; Margioris AN; Dretakis KE; Trovas G; Zoras U; Lyritis G; Dretakis EK; Stergiopoulos K
    Maturitas; 2004 Mar; 47(3):185-93. PubMed ID: 15036488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum concentrations of interleukin 6, osteocalcin, intact parathyroid hormone, and markers of bone resorption in patients with rheumatoid arthritis.
    Al-Awadhi A; Olusi S; Al-Zaid N; Prabha K
    J Rheumatol; 1999 Jun; 26(6):1250-6. PubMed ID: 10381038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum osteocalcin and urinary crosslaps are suitable markers of bone turnover in response to short-term hormone replacement therapy.
    Peichl P; Griesmacher A; Müller MM; Marteau R; Kumpan W; Bröll H
    Gynecol Endocrinol; 2000 Oct; 14(5):374-81. PubMed ID: 11109977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biochemical markers of bone turnover : clinical usefulness in osteoporosis].
    Garnero P; Delmas PD
    Ann Biol Clin (Paris); 1999; 57(2):137-48. PubMed ID: 10210740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markers of bone resorption--measurement in serum, plasma or urine?
    Huber F; Traber L; Roth HJ; Heckel V; Schmidt-Gayk H
    Clin Lab; 2003; 49(5-6):203-7. PubMed ID: 15285175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis.
    Seibel MJ; Cosman F; Shen V; Gordon S; Dempster DW; Ratcliffe A; Lindsay R
    J Bone Miner Res; 1993 Jul; 8(7):881-9. PubMed ID: 8352070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Usefulness of the relationship between follicular stimulating hormone, deoxypyridinoline, estradiol, and inhibin as decision criterion for starting replacement hormone therapy in climacteric and its correlation with symptomatology].
    Carranza Lira S; Cortés Fuentes E; González Legorreta SL
    Ginecol Obstet Mex; 2000 Jun; 68():242-8. PubMed ID: 10939192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer.
    Pollmann D; Siepmann S; Geppert R; Wernecke KD; Possinger K; Lüftner D
    Anticancer Res; 2007; 27(4A):1853-62. PubMed ID: 17649784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of the level of biochemical bone markers: NMID osteocalcin and bone resorptive marker (beta CTx) in Thai women.
    Bunyaratavej N; Kitimanon N; Boonthitikul S
    J Med Assoc Thai; 2001 Oct; 84 Suppl 2():S560-5. PubMed ID: 11853281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global skeletal uptake of 99mTc-methylene diphosphonate (GSU) in patients affected by endocrine diseases: comparison with biochemical markers of bone turnover.
    Scillitani A; Dicembrino F; Chiodini I; Minisola S; Fusilli S; Di Giorgio A; Garrubba M; D'Aloiso L; Frusciante V; Torlontano M; Modoni S; Trischitta V; Trischitta V; Carnevale V
    Osteoporos Int; 2002 Oct; 13(10):829-34. PubMed ID: 12378373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-line therapy with thalidomide, dexamethasone and zoledronic acid decreases bone resorption markers in patients with multiple myeloma.
    Tosi P; Zamagni E; Cellini C; Parente R; Cangini D; Tacchetti P; Perrone G; Ceccolini M; Boni P; Tura S; Baccarani M; Cavo M
    Eur J Haematol; 2006 May; 76(5):399-404. PubMed ID: 16480429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of methods for measuring serum and urinary markers of bone metabolism in cats.
    DeLaurier A; Jackson B; Pfeiffer D; Ingham K; Horton MA; Price JS
    Res Vet Sci; 2004 Aug; 77(1):29-39. PubMed ID: 15120950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A longitudinal study of bone-related biochemical changes at the menopause.
    Nordin BE; WIshart JM; Clifton PM; McArthur R; Scopacasa F; Need AG; Morris HA; O'Loughlin PD; Horowitz M
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):123-30. PubMed ID: 15212654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of four biochemical markers of bone metabolism in postmenopausal osteoporosis.
    Majkić-Singh N; Ilić M; Ignjatović S; Aleksandra-Postić-Grujin
    Clin Lab; 2002; 48(7-8):407-13. PubMed ID: 12146575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical usefulness of the serum N-terminal propeptide of type I collagen as a marker of bone formation in hemodialysis patients.
    Ueda M; Inaba M; Okuno S; Nagasue K; Kitatani K; Ishimura E; Shimizu M; Miki T; Kim M; Nishizawa Y
    Am J Kidney Dis; 2002 Oct; 40(4):802-9. PubMed ID: 12324916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH.
    Ueda M; Inaba M; Okuno S; Maeno Y; Ishimura E; Yamakawa T; Nishizawa Y
    Life Sci; 2005 Jul; 77(10):1130-9. PubMed ID: 15978265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implant design affects markers of bone resorption and formation in total hip replacement.
    Qureshi AA; Virdi AS; Didonna ML; Jacobs JJ; Masuda K; Paprosky WP; Thonar EJ; Sumner DR
    J Bone Miner Res; 2002 May; 17(5):800-7. PubMed ID: 12009010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.